APA (7th ed.) Citation

Hall, R. G., Cole, T. J., Shaw, C., & Alvarez, C. A. (2022, February). The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts. Antibiotics.

Chicago Style (17th ed.) Citation

Hall, Ronald G., Travis J. Cole, Chip Shaw, and Carlos A. Alvarez. "The Risk of Clostridioides Difficile Recurrence After Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts." Antibiotics Feb. 2022.

MLA (9th ed.) Citation

Hall, Ronald G., et al. "The Risk of Clostridioides Difficile Recurrence After Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts." Antibiotics, Feb. 2022.